Menu Search
Equities

Burning Rock Biotech Ltd

6BU0:STU

Burning Rock Biotech Ltd

Actions
  • Price (EUR)5.15
  • Today's Change0.89 / 20.89%
  • Shares traded0.00
  • 1 Year change-36.02%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Burning Rock Biotech Ltd had revenues fall -4.58% from 563.24m to 537.44m, though the company grew net income from a loss of 971.23m to a smaller loss of 653.69m.
Gross margin67.71%
Net profit margin-111.18%
Operating margin-114.20%
Return on assets-48.15%
Return on equity-68.89%
Return on investment-65.09%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Burning Rock Biotech Ltd fell by 310.05m. Cash Flow from Investing was negative at 9.30m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 255.78m for operations while cash used for financing totalled 48.83m.
Cash flow per share--
Price/Cash flow per share--
Book value per share9.13
Tangible book value per share9.12
More ▼

Balance sheet in CNYView more

Burning Rock Biotech Ltd appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio3.11
Quick ratio2.85
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.